Close this search box.
Invest in AllerPops on
Food & BevHealth & Wellness


Liberate Millions from Allergies
Los Alamos, 
Investment type:
(Preferred Stock)
Target raise:
 - $618,000
Minimum investment:​
End date:
Apr 30, 2023

  • ?? Completed clinical trial proves that AllerPops provide allergy relief lasting up to a week.
  • ?? 94.5% efficacy rate for allergy relief, based on a survey of about 100 of our 10,0000+ customers!
  • ?? CEO Dr. Cliff Han, biologist 28 years, 300+ peer reviewed papers & has human genome project exp.
  • ?? Seven patents issued (US & international), protecting both composition & method.
Our Story

We manufacture and distribute AllerPops, an all-natural allergy remedy that relieves airborne allergies for months to years.
Our Ambition

In 5 years, we want to be the primary producer of all-natural, drug-free, and causal correcting allergy relief globally. These projections are not guaranteed.